Monday 8 & Tuesday 9 April

Downloadable PDF

Monday and TuesdayWednesdayThursday

Monday 8 April 2019
ROOM Great Hall
1700 – 1800 Opening Ceremony
ROOM Exhibition Hall
1800 – 1930 Welcome Reception and Sponsor acknowledgement
Opening of Exhibition Hall

 

 

Tuesday 9 April 2019
0615 Fun Run
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
CHAIRS Debashish Danda, Wendy Stevens Jenni Ng, Nazrul Islam
TOPIC VASCULITIS MEET THE EXPERTS: VASCULITIS EVIDENCE INTO PRACTICE
0730 – 0800 Catherine Hill
Giant Cell Arteritis Pathogenesis and Management
Wen Zhang Lorimer Moseley
Explaining Pain to People with Arthritis
0800 – 0830 Alex Hewitt
Emerging Molecular and Genetic Insights into Giant Cell Arteritis
ROOM Great Hall
CHAIRS Ann Morgan, Peter Nash
0830 – 0915 PLENARY SESSION I: EARLY INTERVENTION IN RHEUMATOID ARTHRITIS
John Isaacs
Rheumatoid Arthritis Early Diagnosis and Intervention
0915 – 1000 PLENARY SESSION II: PRECISION MEDICINE IN RHEUMATOID ARTHRITIS
Anne Barton
Treatment Response Prediction in Rheumatoid Arthritis
1000 – 1030 COFFEE BREAK & POSTER VIEWING – EXHIBITION HALL
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
1030 – 1145 Industry symposium sponsored by Bristol-Myers Squibb Industry symposium sponsored by Pfizer Industry symposium sponsored by Amgen Industry symposium sponsored by Janssen
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
CHAIRS Graeme Jones, Tang Ching Lau Tony Kenna, Huji Xu Charles Inderjeeth, Syed Atiqul Haq Navid Adib, Ramnath Misra
TOPIC OSTEOPOROSIS 1 IMMUNOTHERAPY HEALTH ECONOMICS, CONSTRUCTING BETTER MODELS OF CARE PAEDIATRIC RHEUMATOLOGY
1145 – 1210 Emma Duncan
Genetics and New Therapies in Osteoporosis
Jamie Rossjohn
Molecular Basis for MHC-peptide Interactions with T-cells
Lyn March
The Global Burden of Disease
Amita Aggarwal
Juvenile Spondyloarthritis
1210 – 1235 Allison Pettit
Stem Cells and Osteoporosis
Ranjeny Thomas
Antigen-specific Immunotherapy for Autoimmune Rheumatic Diseases
Deborah Marshall
Patient Preferences in Decision Making
Helen Foster
Tackling the Burden of Musculoskeletal Disease in Children; Working Together and a Call to Action
1235 – 1300 Yoon-Kyoung Sung
New Advances for the treatment of Glucocorticoid Induced Osteoporosis
Stuart Mannering
Antigen Discovery – Lessons from T1D
Helen Benham
Telehealth and Rheumatology
Ivan Foeldvari
Uveitis in Children
ROOM Great Hall
1300 – 1430 Industry symposium sponsored by Novartis
1300 – 1430 LUNCH BREAK & POSTER TOURS (ENGLISH & MANDARIN) – EXHIBITION HALL
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
CHAIRS Linda Bradbury, Paul Bird Heather Wisbey, Prasanta Padhan Ghita Harifi, Lisa Cummins Sakae Tanaka
TOPIC SPONDYLOARTHRITIS 1 SCLERODERMA 1 PREGNANCY, BREAST-FEEDING & ARTHRITIS Abstract Presentations
1430 – 1455 Cheng-Chung Wei
Treatment Advances in Axial Spondyloarthritis
Andrea Low
Challenges in the Diagnosis and Management of Pulmonary Hypertension in Systemic Sclerosis
Jisoo Lee
Disease Burden of SLE in Women
Stephen Hall
Safety of Baricitinib: Update from up to 6 years of Treatment in Rheumatoid Arthritis Clinical Trials

Julia New-Tolley
The Utility of the ERS-RA Cardiovascular Risk Calculator in Australian Rheumatoid Arthritis Patients
Chi Chiu Mok
Prevalence and Risk Factors of Serious Infections in Rheumatoid Arthritis Patients Receiving the Biologic/Targeted Synthetic DMARDs
Woo-Joong Kim
Kidney Protective Effects of Urate-Lowering Therapy in Patients with Gout
Philip Robinson
Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol is Very Cost Effective
Kathleen Tymms
Impact of Anti-citrullinated Protein Antibody on Response to Abatacept and TNFi in Patients with Rheumatoid Arthritis in the OPAL Dataset
Manoranjan Behera
Charcot Arthropathy Caused by Syringomyelia and Chiari-Malformation: A Rare Case Series
Hiroki Furuya
An Important Differential Diagnosis of SAPHO Syndrome: Disseminated Nontuberculous Mycobacterial Infection with Neutralizing Anti-IFNγ Autoantibody in Apparently Immunocompetent Patient
Andrisha Inderjeeth
Comparing the Electronic Patient Reported Outcome (ePro) Tool Versus the Paper Reported Outcome (pPro) Tool in Rheumatoid Arthritis Patients
1455 – 1520 Lai-Shan Tam
Treating Spondyloarthritis to Target- Are we Ready?
Ivan Foeldvari
Juvenile Scleroderma
Peter Wong
Vaccines and Arthritis
1520 – 1545 Ramnath Misra
Management of Reactive Arthritis
Susanna Proudman
Management Issues in Scleroderma
Laurel Young
Pregnancy and Arthritis
1545 – 1615 COFFEE BREAK & POSTER VIEWING – EXHIBITION HALL
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
CHAIRS Ian Wicks, Zhanguo Li Catherine Hill, Leslie Schreiber Peter Sternes, Helen Benham Richard Kwiatek, Sam Whittle
TOPIC AMERICAN COLLEGE OF RHEUMATOLOGY SYMPOSIUM VASCULITIS MICROBIOME AND RHEUMATIC DISEASES PAIN IN RHEUMATOLOGY – DIAGNOSIS & MANAGEMENT
1615 – 1640 1615 – 1650
Peter Lipsky
Big Data and Novel Drug Development for SLE
David Burgner
Kawasaki Disease Pathogenesis and Management
Huji Xu
Microbiome Studies in Ankylosing Spondylitis
Lorimer Moseley
Contemporary Pain Care: Be Excited (and Open Minded and Brave…)
1640 – 1705 1650 – 1730
Michael Brenner
Role of Stromal Cells in Rheumatoid Arthritis
Debashish Danda
New Advances in Takayasu Arteritis, Asia-Pacific Data and Collaborative Work
Francesco Ciccia
The Gut and Ankylosing Spondylitis
Lynden Roberts
The 2019 Rheumatologist’s Back Pain Handbook
1705 – 1730 Wen Zhang
IgG4 Vasculitis Pathogenesis and Management
Kristen Demoruelle
Rheumatoid Arthritis Lung and Genital Tract Microbiome
Mary-Anne Fitzcharles
Should Rheumatologists See Patients with Fibromyalgia and Prescribe Marijuana?
ROOM Great Hall M1 & M2 P1 & P2 P3, P4 & P5
1730 – 1830 Industry symposium sponsored by AbbVie
1930 – 2130 Presidential Dinner (by invitation only) Paediatric Rheumatology Cocktail Party Rheumatology Health Professionals Dinner (1900 start)